This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Shanghai Syncores Technologies Inc. Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Caide Tang: Innovator in Pharmaceutical Synthesis
Introduction
Caide Tang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly with his innovative methods for creating valuable compounds. His work has implications for the development of important medications.
Latest Patents
Caide Tang holds a patent for a "Vortioxetine intermediate and synthesis process thereof." This invention provides a new intermediate II and a method for synthesizing it. The method involves diazotizing a compound of formula I as a raw material, followed by halogenation to obtain intermediate II. Subsequently, intermediate II is reacted with a compound III to yield a compound IV, which is then hydrolyzed directly to obtain Vortioxetine, represented by compound V. This intermediate II is crucial for synthesizing Vortioxetine.
Career Highlights
Throughout his career, Caide Tang has worked with several prominent companies in the pharmaceutical industry. He has been associated with Shanghai Syncores Technologies Inc. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug synthesis.
Collaborations
Caide Tang has collaborated with notable professionals in his field, including Gang Wang and Eric Gu. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical processes.
Conclusion
Caide Tang's contributions to pharmaceutical synthesis, particularly through his patent on Vortioxetine, highlight his role as an innovator in the industry. His work continues to influence the development of important medications, showcasing the impact of his inventions.